Stifel Nicolaus Trims Definitive Healthcare (NASDAQ:DH) Target Price to $7.50

Definitive Healthcare (NASDAQ:DH) had its price target lowered by analysts at Stifel Nicolaus from $9.50 to $7.50 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 124.55% from the company’s current price.

A number of other brokerages have also recently weighed in on DH. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Definitive Healthcare from $10.00 to $7.00 and set a “hold” rating for the company in a research note on Thursday, May 9th. William Blair restated an “outperform” rating on shares of Definitive Healthcare in a research report on Tuesday, May 14th. Canaccord Genuity Group decreased their price objective on Definitive Healthcare from $10.00 to $8.00 and set a “hold” rating for the company in a research report on Wednesday, May 8th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a report on Wednesday. Finally, Robert W. Baird decreased their price target on Definitive Healthcare from $8.00 to $6.00 and set a “neutral” rating for the company in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Definitive Healthcare presently has a consensus rating of “Hold” and a consensus target price of $8.45.

Definitive Healthcare Stock Down 41.8 %

Shares of NASDAQ:DH traded down $2.40 during trading on Wednesday, hitting $3.34. 2,328,026 shares of the company were exchanged, compared to its average volume of 721,163. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30. The firm’s 50 day moving average price is $5.55 and its 200-day moving average price is $7.14. The stock has a market capitalization of $393.89 million, a P/E ratio of -1.87, a PEG ratio of 4.32 and a beta of 1.30. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $11.97.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Tuesday, May 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.04). The company had revenue of $63.48 million during the quarter, compared to analyst estimates of $64.00 million. Definitive Healthcare had a negative net margin of 78.16% and a positive return on equity of 0.51%. On average, research analysts predict that Definitive Healthcare will post 0.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Definitive Healthcare

Several institutional investors have recently modified their holdings of DH. Tower Research Capital LLC TRC increased its stake in Definitive Healthcare by 599.6% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock valued at $58,000 after purchasing an additional 4,959 shares in the last quarter. Norden Group LLC purchased a new stake in shares of Definitive Healthcare in the 1st quarter worth about $83,000. Berry Wealth Group LP acquired a new stake in Definitive Healthcare in the 1st quarter valued at about $99,000. Reynders McVeigh Capital Management LLC purchased a new position in Definitive Healthcare during the 4th quarter valued at about $129,000. Finally, Arizona State Retirement System raised its position in Definitive Healthcare by 13.6% during the fourth quarter. Arizona State Retirement System now owns 14,253 shares of the company’s stock worth $142,000 after acquiring an additional 1,701 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.